Quantcast
Last updated on April 18, 2014 at 17:08 EDT

Latest MD Anderson Cancer Center Stories

2013-04-23 12:31:40

Will provide clinical phase instruction, training and supervision for students as part of agreement HOUSTON, April 23, 2013 /PRNewswire/ -- Gene By Gene, Ltd., the Houston-based genomics and genetics testing company, announced that it has signed an agreement with the University of Texas MD Anderson Cancer Center to become one of its affiliated clinical laboratories. Under the agreement, scientists at Gene By Gene's Genomic Research Center will provide the clinical phase instruction,...

2013-04-18 08:32:22

New system sets benchmark in radiation oncology versatility and capabilities HOUSTON, April 18, 2013 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center (Houston, Texas) has purchased two Elekta Versa HD(TM) linear accelerators. The radiation therapy system, which recently received 510(k) clearance from the U.S. Food and Drug Administration, features the versatility to deliver high-volume conventional techniques, in addition to the most advanced linear-accelerator...

2012-06-04 02:26:37

PLANTATION, Fla. and HOUSTON, June 4, 2012 /PRNewswire/ -- Goodwin Biotechnology, Inc. (GBI) and The University of Texas MD Anderson Cancer Center jointly announce a collaboration for process development and GMP manufacturing of a fusion protein composed of a vascular endothelial growth factor (VEGF) and the recombinant toxin, Gelonin (rGel), conjugated to a DOTA chelator. The fusion protein targets the tumor neovasculature, or blood supply, and inhibits tumor growth, and the...

2012-04-24 12:47:04

The first McNair Symposium, featuring the work of McNair Medical Institute Scholars in the Texas Medical Center, will be held at Baylor College of Medicine Wednesday, April 25. The symposium will become an annual event and is in keeping with the Robert and Janice McNair Foundation's focus on collaboration and the sharing of research among those who have been named McNair Medical Institute Scholars. The five MMI Scholars at BCM will present research, as will a MMI Scholar at MD Anderson...

2011-11-04 10:07:00

ORLANDO, Fla., Nov. 4, 2011, /PRNewswire-USNewswire/ -- Mark Roh, M.D., an internationally renowned liver cancer surgeon has been named Incoming President of MD Anderson Cancer Center Orlando and will take over as President next year. Dr. Roh also serves as the cancer center's Medical and Scientific Director, overseeing all clinical activities within the cancer center and clinical, basic and translational research programs. As President, Dr. Roh will expand on his administrative functions...

2010-12-14 08:00:00

HOUSTON, Dec. 14, 2010 /PRNewswire/ -- TransTech Medical Solutions is pleased to announce the expansion of their transcription services agreement with MD Anderson Cancer Center. The new agreement increases the suite of services that TransTech provides to MD Anderson to include traditional transcription and voice recognition editing services across a variety of software platforms. Information about the full range of medical transcription and editing services provided by TransTech can be...

2008-10-08 09:00:50

Castle Biosciences, a cancer diagnostics company, has signed an option agreement for a brain cancer test with the University of Texas MD Anderson Cancer Center. The brain cancer test is a molecular diagnostic test developed and validated at The University of Texas MD Anderson Cancer Center to prospectively demonstrate responsiveness to treatment for glioblastoma multiforme, the most common form of primary brain cancer. This diagnostic test, developed and validated at MD Anderson Cancer...